Study of romiplostim for low platelets from sepsis
Part of Infections clinical trials.
This trial tests a drug called romiplostim to see if it can safely raise platelet counts in people with sepsis (a severe infection that can cause organ damage). If you have low platelets due to sepsis, this treatment might help reduce bleeding risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have sepsis, which means a confirmed or suspected infection that has caused organ problems.
- Your platelet count must be 50 or lower (very low).
- You must not have recently taken blood thinners or other platelet-raising treatments.
- You must not have had cancer treatment, transplants, or certain severe health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether platelet transfusions help patients with sepsis and very low platelet counts recover better. If you or your loved one had sepsis, a low platelet count, and were in the ICU for at least two days, this trial may be relevant.
This trial tests a drug called romiplostim for patients whose platelet counts stay very low (below 30) for a long time after chemotherapy, even after other treatments have failed. The goal is to see if romiplostim can help raise your platelet count to a safer level.
This trial tests a drug called Romiplostim to help raise low platelet counts caused by leukemia treatment. It is for adults with leukemia whose platelets are below 50 and who may benefit from this therapy.
This trial tests if romiplostim, a drug that helps the body make platelets, can speed up platelet recovery after a special type of stem cell transplant from a half-matched donor. It may help reduce bleeding risk during the recovery period.
This trial tests a new version of a drug called romiplostim to help raise platelet counts in breast cancer patients whose platelets drop because of chemotherapy. Raising your platelets may reduce the risk of bleeding and allow you to continue your cancer treatment.
This study tests a drug called romiplostim to help your body make platelets faster after a stem cell transplant. Platelets help your blood clot, and getting them back sooner can reduce bleeding risks and speed recovery.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.